CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522007292
- Phone
- (858) 704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- 4 Option exercise Director acquired 12,800 shares (option exercise)
- 4 Shares withheld for taxes Chief Medical Officer gave up 2,153 shares (to pay taxes)
- 4 Option exercise CEO, CFO, Director acquired 6,642 shares (option exercise)
- 4 Open-market buy CEO, CFO, Director bought 10,000 shares at $0.47 ($4,692)
- 4 Open-market buy CEO, CFO, Director bought 10,000 shares at $0.56 ($5,590)
- 4 Open-market buy Director bought 10,000 shares at $0.61 ($6,050)
- 4 Option exercise CEO, CFO, Director acquired 1,309 shares (option exercise)
- 4 Option exercise CEO, CFO, Director acquired 5,559 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CEO, CFO, Director acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,630 shares (to pay taxes)
- 4 Option exercise CEO, CFO, Director acquired 3,475 shares (option exercise)
- 4 Shares withheld for taxes CEO, CFO, Director gave up 397 shares (to pay taxes)
Page 4 of 18 · 343 filings